Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Net Income of $214.33 million for fiscal year 2025.
CATALYST PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $214.33M | +30.8% |
| 2024 | $163.89M | +129.5% |
| 2023 | $71.41M | -14.0% |
| 2022 | $83.08M | +110.4% |
| 2021 | $39.48M | -47.3% |
| 2020 | $74.98M | +135.2% |
| 2019 | $31.88M | +193.7% |
| 2018 | -$34.00M | -84.7% |
| 2017 | -$18.41M | -1.9% |
| 2016 | -$18.07M | +10.7% |
| 2015 | -$20.23M | -30.5% |
| 2014 | -$15.51M | -27.6% |
| 2013 | -$12.15M | -198.2% |
| 2012 | -$4.08M | +36.2% |
| 2011 | -$6.39M | -59.5% |
| 2010 | -$4.01M | +44.7% |
| 2009 | -$7.24M | +31.5% |
| 2008 | -$10.56M | -155.2% |
| 2007 | -$4.14M | -51.7% |
| 2006 | -$2.73M | -51.2% |
| 2005 | -$1.81M | -234.4% |
| 2004 | -$539.8K | -25.9% |
| 2003 | -$428.6K | -67.5% |
| 2002 | -$255.9K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $52.78M | +20.3% | +1.3% |
| June 30, 2025 | $52.11M | +27.7% | -8.2% |
| March 31, 2025 | $56.74M | +143.8% | +29.3% |
| September 30, 2024 | $43.88M | +242.6% | +7.6% |
| June 30, 2024 | $40.79M | +8.0% | +75.3% |
| March 31, 2024 | $23.27M | -21.3% | +175.7% |
| September 30, 2023 | -$30.76M | -235.2% | -181.5% |
| June 30, 2023 | $37.76M | +74.7% | +27.7% |
- CATALYST PHARMACEUTICALS, INC. showed an increase of +30.8% in Net Income compared to the prior fiscal year.
- Over the 2002–2025 period, CATALYST PHARMACEUTICALS, INC.’s net income has grown by 83839.1% (from -$255.9 thousand to $214.33 million).
- The most recent figure is from CATALYST PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: